Millennium Pharmaceuticals, Inc.
🏢 View company profile →919Patents
313Active
919Granted
51Portfolio score
Filing activity: Aug 23, 1994 → Feb 5, 2024 · 149 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7285565B2 | Benzamides and related inhibitors of factor Xa | Chemistry; Metallurgy | 154 | Expired |
| US6297217A | Boronic ester and acid compounds, synthesis and uses | Human Necessities | 133 | Expired |
| US6562343B1 | Compositions and methods for the treatment and diagnosis of immune disorders | Emerging Cross-Sectional Technologies | 109 | Expired |
| US6414117B1 | Compositions and methods for the treatment and diagnosis of immune disorders | Emerging Cross-Sectional Technologies | 104 | Expired |
| US6124433A | Compositions and methods for treatment and diagnosis of cardiovascular disease | Human Necessities | 103 | Expired |
| US7705120B2 | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | Chemistry; Metallurgy | 91 | Expired |
| US7029895B2 | 27411, a novel human PGP synthase | Physics | 87 | Expired |
| US6534535B1 | Inhibitors of factor Xa | Chemistry; Metallurgy | 87 | Expired |
| US6979564B2 | 80090, human fucosyltransferase nucleic acid molecules and uses thereof | Chemistry; Metallurgy | 86 | Expired |
| US6156500A | Methods for the treatment and diagnosis of cardiovascular disease | Human Necessities | 84 | Expired |
| US6617317B1 | Boronic ester and acid compositions | Human Necessities | 82 | Expired |
| US7482147B2 | Ubiquitin protease | Physics | 81 | Active |
| US6844367B1 | Benzamides and related inhibitors of factor Xa | Chemistry; Metallurgy | 80 | Expired |
| USD866757S1 | Autoinjector | General | 79 | Active |
| US8323906B2 | Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer | Physics | 75 | Active |
| US6696550B2 | Humanized anti-CCR2 antibodies and methods of use therefor | Chemistry; Metallurgy | 73 | Expired |
| US8765773B2 | Substituted hydroxamic acids and uses thereof | Chemistry; Metallurgy | 69 | Active |
| US6835739B2 | Benzamides and related inhibitors of factor Xa | Chemistry; Metallurgy | 66 | Expired |
| US6291193A | MTbx protein and nucleic acid molecules and uses therefor | Chemistry; Metallurgy | 66 | Expired |
| US6632815B2 | Inhibitors of factor Xa | Chemistry; Metallurgy | 65 | Expired |
| US6204371A | Compositions and methods for the treatment and diagnosis of immune disorders | Emerging Cross-Sectional Technologies | 63 | Expired |
| US7442830B1 | Proteasome inhibitors | Chemistry; Metallurgy | 62 | Active |
| US7494775B2 | Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer | Physics | 60 | Expired |
| US6699835B2 | Formulation of boronic acid compounds | Human Necessities | 57 | Expired |
| US6395498B1 | Methods of identifying compounds that modulate body weight using the OB receptor | Chemistry; Metallurgy | 56 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.